Could shedding assets spell a breakthrough for troubled GE?
General Electric today announced the sale of its biopharmaceutical business for more than $21 billion dollars. The buyer is Danaher Corporation, which happens to have been previous…
General Electric today announced the sale of its biopharmaceutical business for more than $21 billion dollars. The buyer is Danaher Corporation, which happens to have been previous…